These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30160591)

  • 21. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma.
    Cooling L; Hoffmann S; Herrst M; Muck C; Armelagos H; Davenport R
    Transfusion; 2010 Jan; 50(1):100-19. PubMed ID: 19719472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
    Moreb JS; Byrne M; Shugarman I; Zou F; Xiong S; May WS; Norkin M; Hiemenz J; Brown R; Cogle C; Wingard JR; Hsu JW
    J Clin Apher; 2018 Feb; 33(1):29-37. PubMed ID: 28556233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
    Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
    J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma.
    Ozsan GH; Micallef IN; Dispenzieri A; Kumar S; Lacy MQ; Dingli D; Hayman SR; Buadi FK; Wolf RC; Gastineau DA; Hogan WJ; Gertz MA
    Am J Hematol; 2012 Jan; 87(1):1-4. PubMed ID: 21959988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
    Martino M; Recchia AG; Moscato T; Fedele R; Neri S; Gentile M; Alati C; Vincelli ID; Piro E; Penna G; Musolino C; Ronco F; Molica S; Morabito F
    Cytotherapy; 2015 Oct; 17(10):1485-93. PubMed ID: 26188967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone.
    Benyamini N; Avivi I; Dann EJ; Zuckerman T; Lavi N; Katz T
    Ann Hematol; 2017 Mar; 96(3):461-467. PubMed ID: 28013359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fresh or Cryopreserved CD34
    Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
    Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
    Sahebi F; Iacobelli S; Sbianchi G; Koster L; Blaise D; Reményi P; Russell NH; Ljungman P; Kobbe G; Apperley J; Trneny M; Krejci M; Wiktor-Jedrzejczak W; Sanchez JF; Schaap N; Isaksson C; Lenhoff S; Browne P; Scheid C; Wilson KMO; Yakoub-Agha I; Muñiz SG; Schönland S; Morris C; Garderet L; Kröger N
    Biol Blood Marrow Transplant; 2018 May; 24(5):930-936. PubMed ID: 29339268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery.
    Ungerstedt JS; Watz E; Uttervall K; Johansson BM; Wahlin BE; Näsman P; Ljungman P; Gruber A; Axdorph Nygell U; Nahi H
    Med Oncol; 2012 Sep; 29(3):2191-9. PubMed ID: 21779930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inferior prognosis in poor mobilizing myeloma patients.
    Yiğenoğlu TN; Başcı S; Ulu BU; Bakırtaş M; Kılınç A; Şahin D; Darçın T; Yıldız J; Baysal NA; İskender D; Çakar MK; Dal MS; Hacıbekiroğlu T; Altuntaş F
    Transfus Apher Sci; 2020 Jun; 59(3):102722. PubMed ID: 32014363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients.
    Jantunen E; Varmavuo V; Pelkonen J; Valtola J
    Leuk Lymphoma; 2019 Sep; 60(9):2115-2121. PubMed ID: 30843749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) - a focus on healthcare resource utilization and cost.
    Iida S; Ishida T; Horimoto K; Kazama H; Kim H; Crawford B; Teshima T
    Int J Hematol; 2021 Feb; 113(2):271-278. PubMed ID: 33063174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
    Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
    Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03).
    van de Wyngaert Z; Malard F; Hulin C; Caillot D; Mariette C; Facon T; Touzeau C; Perrot A; Moreau P; Hebraud B; Kanouni T; Heshmati F; Lebon D; Mohty M; Chabannon C
    Clin Hematol Int; 2023 Mar; 5(1):38-42. PubMed ID: 36781774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
    Herr MM; Torka P; Zhang Y; Wallace PK; Tario JD; Repasky EA; Chen GL; Ho CM; Balderman SR; Ross M; Paiva B; Hernandez-Ilizaliturri FJ; McCarthy PL; Hahn T
    Bone Marrow Transplant; 2020 Jan; 55(1):77-85. PubMed ID: 31227776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study.
    Turunen A; Valtola J; Partanen A; Ropponen A; Kuittinen O; Kuitunen H; Vasala K; Ågren L; Penttilä K; Keskinen L; Savolainen ER; Pyörälä M; Kuittinen T; Selander T; Mäntymaa P; Pelkonen J; Jantunen E; Varmavuo V
    Leuk Lymphoma; 2020 Sep; 61(9):2082-2092. PubMed ID: 32419549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plerixafor-based mobilization and mononuclear cell counts in graft increased the risk of engraftment syndrome after autologous hematopoietic stem cell transplantation.
    Cao LQ; Wen Q; Liu BN; Zhao ZY; Zhang XH; Xu LP; Chen H; Wang Y; Yu L; Wang FR; Huang XJ; Mo XD
    Blood Sci; 2024 Jul; 6(3):e00190. PubMed ID: 38779304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD34
    Turunen AS; Kuittinen O; Kuitunen H; Vasala K; Penttilä K; Harmanen M; Keskinen L; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E; Partanen A
    Transfus Med Hemother; 2023 Oct; 50(5):428-437. PubMed ID: 37899989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma.
    Partanen A; Kuittinen O; Turunen A; Valtola J; Pyorala M; Kuitunen H; Vasala K; Kuittinen T; Mantymaa P; Pelkonen J; Jantunen E; Varmavuo V
    J Hematol; 2021 Dec; 10(6):246-254. PubMed ID: 35059086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.